Par Drugs & Chemicals Ltd Locks at Lower Circuit With 5.0% Loss — Sellers Queue, No Buyers in Sight

Circuit Event and Unfilled Supply

The stock, trading in the BE series, hit its maximum allowed daily loss of 5.0%, the limit set by the exchange for this price band. The closing price of Rs 134.37 was also the intraday low, indicating that the stock remained locked at the floor price throughout the session. This scenario reflects a classic lower circuit event where supply overwhelmed demand to the point that the exchange's circuit breaker intervened, effectively freezing trading at the floor price. Sellers were lined up, but buyers were absent, creating a significant unfilled supply on the order book. Par Drugs & Chemicals Ltd is a micro-cap stock with a market capitalisation of Rs 165.34 crore, a segment where such liquidity constraints are more pronounced. Par Drugs & Chemicals Ltd's lower circuit event highlights the challenges sellers face in exiting positions when demand dries up so completely — how deep is the exit problem for this micro-cap and what would need to change for normal trading to resume?

Delivery and Volume Analysis

Contrary to what might be expected in a sell-off, delivery volumes for Par Drugs & Chemicals Ltd were zero on 08 Sep 2026, representing a 100% decline against the 5-day average delivery volume. This suggests that the selling pressure on the lower circuit day was not driven by holders liquidating their actual shareholdings but rather by speculative short-selling or intraday trades. Total traded volume was 0.08933 lakh shares, with a turnover of Rs 0.12 crore, which is relatively low and consistent with the circuit lock limiting trade execution. The delivery data on a lower circuit day has a specific meaning — and it's not the same as on an upper circuit — does this pattern indicate a capitulation or a more technical, speculative sell-off?

Intraday Price Action

The intraday range was narrow, with the stock opening and closing at Rs 134.37, the lower circuit price. The high for the day was Rs 134.37 as well, indicating that the stock did not trade above the circuit floor at any point during the session. This suggests that the selling pressure was persistent from the outset, with no meaningful attempt by buyers to absorb the supply. The lack of intraday recovery reinforces the impression of a market where sellers were unable to find counterparties, and the circuit breaker effectively locked the price to prevent further decline. does the absence of intraday bounce signal exhaustion or the potential for continued pressure?

Moving Averages and Trend Context

Interestingly, Par Drugs & Chemicals Ltd closed below its 5-day moving average but remained above the 20-day, 50-day, 100-day, and 200-day moving averages. This mixed technical picture suggests that while short-term momentum is weak, the longer-term trend has not yet fully turned bearish. However, the lower circuit event may accelerate downward pressure if the stock fails to regain footing above the short-term averages. The 5-day moving average acting as immediate resistance could be a critical hurdle. does the technical profile of Par Drugs & Chemicals Ltd show any nearby support, or is more downside likely?

Liquidity and Exit Risk

As a micro-cap stock with a market capitalisation of Rs 165.34 crore, Par Drugs & Chemicals Ltd faces inherent liquidity challenges. The average traded value over five days suggests the stock is liquid enough for a trade size of approximately Rs 0.15 crore, but on the lower circuit day, turnover was only Rs 0.12 crore. This discrepancy highlights the exit risk for holders attempting to sell meaningful positions. The circuit lock compounds this problem by freezing the price at the floor, preventing sellers from exiting at any price above the lower circuit. For micro-cap stocks, this can lead to multi-day circuit locks, trapping sellers on the wrong side of the trade. how severe is the liquidity exit risk for this stock and what might it mean for trading in the coming sessions?

Fundamental Context

Par Drugs & Chemicals Ltd operates in the Chemicals & Petrochemicals sector, a space that often experiences volatility linked to raw material prices and regulatory factors. While the company’s micro-cap status limits its market liquidity, its fundamentals have not been the primary driver of this sharp price move. The 5.0% decline on 09 Sep 2026 contrasts with the sector’s modest 0.25% loss and the Sensex’s 0.45% decline, underscoring the stock-specific nature of this sell-off.

Conclusion: Severity and Liquidity Caveats

The lower circuit lock at a 5.0% loss for Par Drugs & Chemicals Ltd reflects a session where sellers overwhelmed demand to the extent that the exchange halted further price declines. The absence of delivery volume suggests speculative selling rather than holder capitulation, but the liquidity constraints inherent in a micro-cap stock amplify the exit risk. The stock’s position below the 5-day moving average confirms short-term weakness, while the narrow intraday range at the circuit floor indicates persistent selling pressure with no relief. Locked at lower circuit with sellers queuing — is this capitulation or just the beginning for Par Drugs & Chemicals Ltd? The multi-factor analysis has the answer.

Liquidity and Exit Risk Warning: As a micro-cap stock, Par Drugs & Chemicals Ltd carries heightened liquidity risk. Lower circuit events can trap sellers for multiple sessions, making it difficult to exit positions without significant price concessions. Investors should be mindful of these risks when trading or holding micro-cap stocks experiencing circuit locks.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today